SAMUEL NEUHUT: Open Payments
NPI 1750609244 · AVENTURA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$801 in 35 payments from 12 companies in 2025. Trend: 2023 $586 · 2024 $802 · 2025 $801
Food & beverage: $801
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 10 | $145 |
| Corium, LLC | 5 | $140 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $117 |
| ABBVIE INC. | 4 | $112 |
| E.R. Squibb & Sons, L.L.C. | 4 | $87 |
| Otsuka America Pharmaceutical, Inc. | 2 | $41 |
| Almatica Pharma LLC | 1 | $32 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $28 |
| Lundbeck LLC | 1 | $26 |
| Axsome Therapeutics, Inc. | 1 | $26 |
Products named: Azstarys, AUSTEDO XR, CAPLYTA, VRAYLAR, COBENFY, REXULTI, LOREEV XR, TRINTELLIX.
Industry payments across FL — which companies pay providers there.
